Bausch Lomb Corp (BLCO)

May 02, 2025

Bausch & Lomb stock target cut to $15 at H.C. Wainwright By Investing.com - Investing.com South Africa

May 02, 2025

May 02, 2025

Bausch & Lomb stock target cut to $15 at H.C. Wainwright - Investing.com Nigeria

May 02, 2025

May 02, 2025

Bausch & Lomb (BLCO) Receives Adjusted Price Target by HC Wainwright & Co. | BLCO Stock News - GuruFocus

May 02, 2025

May 02, 2025

Bausch + Lomb (BLCO) Price Target Cut by Analyst Amid Tariff Concerns | BLCO Stock News - GuruFocus

May 02, 2025

May 02, 2025

Citi Maintains Neutral Rating on Bausch & Lomb (BLCO), Lowers Pr - GuruFocus

May 02, 2025

May 01, 2025

Bausch + Lomb (BLCO) Shares Plunge After Weak Q1 2025 Results - GuruFocus

May 01, 2025

May 01, 2025

Bausch & Lomb (BLCO) Target Price Lowered by Evercore ISI Group - GuruFocus

May 01, 2025

May 01, 2025

Bausch & Lomb (BLCO) Target Price Lowered by Wells Fargo | BLCO Stock News - GuruFocus

May 01, 2025

May 01, 2025

Bausch + Lomb Corporation (NYSE:BLCO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 01, 2025

May 01, 2025

Bausch + Lomb (BLCO) Faces Price Target Cut Amid Financial Press - GuruFocus

May 01, 2025

May 01, 2025

Bausch + Lomb (BLCO) Sees Adjusted Price Target Amidst Earnings Update | BLCO Stock News - GuruFocus

May 01, 2025

May 01, 2025

Bausch + Lomb (BLCO) Reports Q1 Revenue Slightly Below Expectati - GuruFocus

May 01, 2025

May 01, 2025

Bausch + Lomb (BLCO) Price Target Reduced by Citi After Q1 Repor - GuruFocus

May 01, 2025

May 01, 2025

Bausch + Lomb (BLCO) Misses Revenue Expectations in Q1, Shares D - GuruFocus

May 01, 2025

Apr 30, 2025

Bausch + Lomb (BLCO) Misses Q1 Estimates, Lowers Growth Outlook - GuruFocus

Apr 30, 2025

Apr 30, 2025

Bausch & Lomb Reports Weak Start to 2025 as enVista Recall, Tariffs, and Drug Pricing Cause Concerns - Morningstar

Apr 30, 2025

Apr 30, 2025

Bausch & Lomb Corp SEC 10-Q Report - TradingView

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb stock hits 52-week low at $10.46 By Investing.com - Investing.com India

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb stock hits 52-week low at $10.46 - Investing.com Australia

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb shares tumble as Q1 earnings miss expectations By Investing.com - Investing.com Canada

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb shares tumble as Q1 earnings miss expectations - Investing.com

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb Announces First-Quarter 2025 Results - BioSpace

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb (BLCO) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb Q1 2025 slides: Revenue grows 5% despite enVista recall impact - Investing.com

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb (BLCO) Updates FY25 Financial Outlook | BLCO Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb: Q1 Earnings Snapshot - Barchart.com

Apr 30, 2025

Apr 30, 2025

Bausch + Lomb Q1 2025 Financial Results - TradingView

Apr 30, 2025

Apr 29, 2025

Wells Fargo maintains Bausch & Lomb stock with $15 target By Investing.com - Investing.com Canada

Apr 29, 2025

Apr 29, 2025

Bausch + Lomb (BLCO) Reports Q1: Everything You Need To Know Ahead Of Earnings - Barchart.com

Apr 29, 2025

Apr 24, 2025

Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall - BioSpace

Apr 24, 2025

Apr 24, 2025

Bausch + Lomb Corporation - Baystreet.ca

Apr 24, 2025

Apr 24, 2025

Bausch + Lomb resumes enVista IOL production after recall - Investing.com

Apr 24, 2025

Apr 23, 2025

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for - MSN

Apr 23, 2025

Apr 22, 2025

Billionaire Carl Icahn builds 34% economic interest in Bausch Health - Reuters

Apr 22, 2025

Apr 22, 2025

Is Bausch + Lomb (BLCO) the Most Undervalued Canadian Stock to Buy According to Wall Street Analysts? - Yahoo Finance

Apr 22, 2025

Apr 17, 2025

Fitch upgrades Bausch + Lomb rating, maintains evolving watch - Investing.com

Apr 17, 2025

Apr 17, 2025

Fitch upgrades Bausch + Lomb rating, maintains evolving watch By Investing.com - Investing.com Canada

Apr 17, 2025

Apr 17, 2025

Fitch Upgrades Bausch + Lomb, Bausch Health But Keeps Both Junk - Bloomberg.com

Apr 17, 2025

Apr 16, 2025

Bausch & Lomb Corp (BLCO) Shares Down 3.1% on Apr 15 - GuruFocus

Apr 16, 2025

Apr 10, 2025

Bausch & Lomb Agrees to End Vitamin-Patent Suit Ahead of Trial - Bloomberg Law News

Apr 10, 2025

Apr 10, 2025

Bausch + Lomb (BLCO) Moves 13.9% Higher: Will This Strength Last? - Yahoo

Apr 10, 2025

Apr 08, 2025

Ophthalmic Devices Market Set to Attain Valuation of US$ 83.33 Billion By 2033 | Astute Analytica - GlobeNewswire Inc.

Apr 08, 2025

Apr 08, 2025

Bausch + Lomb Recalls Certain EnVista Intraocular Lenses - Nasdaq

Apr 08, 2025

Apr 07, 2025

Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & SuppliesSpecialty Segment - Yahoo Finance

Apr 07, 2025

Apr 05, 2025

Bausch + Lomb Gears Up For Q1 2025 Results Announcement - Finimize

Apr 05, 2025

Apr 04, 2025

RBC Capital cuts Bausch & Lomb price target to $17, maintains Outperform - Investing.com

Apr 04, 2025

Apr 03, 2025

Stifel cuts Bausch & Lomb stock target to $15, maintains hold - Investing.com

Apr 03, 2025

Mar 31, 2025

Lawyers focus on Bausch + Lomb recall investigation | 2025-03-31 | Investing News - Stockhouse

Mar 31, 2025

Mar 28, 2025

Bausch & Lomb Patents’ Validity Should Go to Trial, Judge Says - Bloomberg Law News

Mar 28, 2025

Mar 28, 2025

WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty - Baystreet.ca

Mar 28, 2025

Mar 28, 2025

Wells Fargo cuts Bausch & Lomb stock rating, lowers target to $15 - Investing.com UK

Mar 28, 2025

Mar 27, 2025

Bausch + Lomb recalls some of its implantable eye lenses - Reuters

Mar 27, 2025